A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors

NCT02596503 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Solid Tumors
Refractory Solid Tumors

Interventions

DRUG: Eribulin
DRUG: Irinotecan
OTHER: Cefixime

Sponsor

University of Colorado, Denver

Collaborators

[object Object]